Abingdon Health Plc (AIM:ABDX)

Market Cap	31.42M +20.9%
Revenue (ttm)	9.57M +40.4%
Net Income	-3.24M
EPS	-0.01
Shares Out	433.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,410
Average Volume	281,172
Open	7.50
Previous Close	7.25
Day's Range	7.10 - 7.50
52-Week Range	5.10 - 9.00
Beta	0.25
RSI	45.23
Earnings Date	Mar 17, 2026

About Abingdon Health

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 124
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ABDX

Financial Performance

In fiscal year 2025, Abingdon Health's revenue was 8.43 million, an increase of 37.39% compared to the previous year's 6.14 million. Losses were -3.42 million, 168.7% more than in 2024.